Meningiomas are often considered a mark of severity in NF2 disease and are employed as prognostic features for genomic counseling (Halliday et al., 2017); this inconsistent presentation of disease severity within one family epitomizes the challenge of defining the effect and function of such missense variants. Here, NF2 is linked to meningioma.